HUNTSMAN CAROLE (Chief Commercial Officer) sold 3.2% of their position (419.00 shares) of MADRIGAL PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $181.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/6/2026ACC: 0001628280-26-015758
Officer· Chief Commercial Officer
Since Mar 2026
+8.56K
Net shares
Net buyer
$181.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
8.97K acquired · 419.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+3.99K
Price / share
—
Trade value
—
% of position
43.7%
3/4/2026
9.12K→13.11K
Common Stock
Direct
Shares
−419.00
Price / share
$431.94
Trade value
$180.98K
% of position
3.2%
3/6/2026
13.11K→12.69K
Total
Net shares
+3.57K
Net value
-$180.98K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/4/2026 | A · Award | +3.99K | — | — | 43.7% | 9.12K | 13.11K |
| Common Stock Direct | 3/6/2026 | S · Sale | −419.00 | $431.94 | $180.98K | 3.2% | 13.11K | 12.69K |
| Total | +3.57K | -$180.98K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
4.99K shares
Shares
+4.99K
Strike price
434.80
Held after
4.99K
Exercisable
—
3/4/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock4.99K shares | 3/4/2026 | A · Award | +4.99K | 434.80 | — | 4.99K |